RS Oncology LLC
🇺🇸United States
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma
Phase 1
Recruiting
- Conditions
- Mesotheliomas PleuralMesothelioma; LungMalignant Pleural EffusionMalignant Pleural MesotheliomaPleural Effusion, MalignantMesothelioma
- Interventions
- First Posted Date
- 2022-03-15
- Last Posted Date
- 2024-01-26
- Lead Sponsor
- RS Oncology LLC
- Target Recruit Count
- 186
- Registration Number
- NCT05278975
- Locations
- 🇬🇧
South Mead North Bristol Hopsital, Bristol, United Kingdom
🇬🇧NHS Greater Glasgow & Clyde, Glasgow, United Kingdom
🇬🇧Leeds Teaching Hospital, Leeds, United Kingdom
News
No news found